Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature
- 20 July 2010
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 90 (1) , 101-106
Abstract
The rate of asymptomatic amyloidosis (AL) among patients with newly diagnosed multiple myeloma (MM) or smoldering multiple myeloma (SMM) is unknown. We evaluated number and clinical significance of asymptomatic AL in consecutive MM and SMM patients, not having recognition of symptomatic AL at the time of their diagnostic bone marrow biopsy. Bone marrow biopsies were stained with Congo red and considered diagnostic for AL in case of positive Congo red staining with apple-green birefringence. Biopsies from 144 patients were evaluated: 77 had a diagnosis of MM and 67 of SMM. The median age was 59 (range 26–84) years; the median follow-up was 76 months (range 0–216). Immunoglobulin isotypes were 96/144 (67%), IgG; 23/144 (16%), IgA; 12/144 (8%), light chain only; 1/77 (1%), IgD; and biclonal or indeterminate, 12/144 (8%). Fifty-eight percent (84/144) were κ restricted. The presence of amyloid was found in two cases (1%, 95% CI −0.6 to 3.2), one in MM, and one in SMM group, and none had or developed signs or symptoms suggestive of organ involvement by amyloid. Among the 142 other patients without amyloid deposition in their index bone marrow, one (0.7%, 95% CI −0.6 to 2.0) developed symptomatic AL after 119 months.Keywords
This publication has 11 references indexed in Scilit:
- Amyloid in bone marrow smears of patients affected by multiple myelomaAnnals of Hematology, 2009
- Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factorAnnals of Hematology, 2008
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?Bone Marrow Transplantation, 2006
- Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and TreatmentMayo Clinic Proceedings, 2006
- Guidelines on the diagnosis and management of AL amyloidosisBritish Journal of Haematology, 2004
- AMYLOIDOSISHematology/Oncology Clinics of North America, 1999
- Primary systemic amyloidosis with delayed progression to multiple myelomaCancer, 1998
- Incidence and Impact of Light Chain Associated (AL) Amyloidosis on the Prognosis of Patients with Multiple Myeloma Treated with Autologous TransplantationLeukemia & Lymphoma, 1997
- Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years' experienceThe American Journal of Medicine, 1987